Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Bladder, Neurogenic | 4 | 2023 | 165 | 1.190 |
Why?
|
Urinary Bladder, Overactive | 2 | 2021 | 106 | 0.870 |
Why?
|
Neuromuscular Agents | 2 | 2021 | 134 | 0.860 |
Why?
|
Varicocele | 1 | 2023 | 78 | 0.850 |
Why?
|
Synaptotagmin II | 1 | 2021 | 15 | 0.820 |
Why?
|
Synaptotagmin I | 1 | 2021 | 36 | 0.800 |
Why?
|
Botulinum Toxins, Type A | 2 | 2021 | 213 | 0.770 |
Why?
|
Spermatic Cord Torsion | 1 | 2020 | 73 | 0.720 |
Why?
|
Botulinum Toxins | 1 | 2021 | 191 | 0.710 |
Why?
|
Laparoscopy | 3 | 2024 | 2151 | 0.540 |
Why?
|
Nerve Block | 1 | 2021 | 644 | 0.490 |
Why?
|
Reperfusion Injury | 1 | 2020 | 1026 | 0.460 |
Why?
|
Cystectomy | 1 | 2019 | 686 | 0.460 |
Why?
|
Shiga-Toxigenic Escherichia coli | 2 | 2022 | 28 | 0.410 |
Why?
|
Hemolytic-Uremic Syndrome | 2 | 2022 | 110 | 0.400 |
Why?
|
Escherichia coli Infections | 2 | 2022 | 532 | 0.310 |
Why?
|
Length of Stay | 2 | 2019 | 6309 | 0.280 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2019 | 2245 | 0.270 |
Why?
|
Scrotum | 1 | 2023 | 115 | 0.210 |
Why?
|
Urinary Bladder | 3 | 2014 | 1172 | 0.210 |
Why?
|
Sclerotherapy | 1 | 2023 | 175 | 0.200 |
Why?
|
Shiga Toxins | 1 | 2021 | 41 | 0.200 |
Why?
|
Trihexosylceramides | 1 | 2021 | 32 | 0.200 |
Why?
|
Fecal Incontinence | 1 | 2024 | 239 | 0.200 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 418 | 0.180 |
Why?
|
Regeneration | 3 | 2014 | 1485 | 0.170 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2021 | 264 | 0.170 |
Why?
|
Urinary Diversion | 1 | 2019 | 138 | 0.160 |
Why?
|
Urography | 1 | 2019 | 313 | 0.160 |
Why?
|
Proteoglycans | 1 | 2021 | 835 | 0.160 |
Why?
|
Urologic Diseases | 1 | 2019 | 244 | 0.150 |
Why?
|
Testis | 1 | 2020 | 803 | 0.140 |
Why?
|
Urinary Tract | 1 | 2019 | 309 | 0.140 |
Why?
|
Atrophy | 1 | 2020 | 1583 | 0.130 |
Why?
|
Spinal Cord Injuries | 1 | 2023 | 931 | 0.130 |
Why?
|
Antigens | 1 | 2021 | 1466 | 0.130 |
Why?
|
Bacterial Toxins | 1 | 2021 | 931 | 0.130 |
Why?
|
Hernia, Inguinal | 1 | 2017 | 210 | 0.130 |
Why?
|
Models, Animal | 1 | 2021 | 2171 | 0.130 |
Why?
|
Nanofibers | 1 | 2014 | 66 | 0.120 |
Why?
|
Citrates | 2 | 2013 | 131 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2019 | 1462 | 0.110 |
Why?
|
Multipotent Stem Cells | 1 | 2013 | 186 | 0.100 |
Why?
|
Ischemia | 1 | 2020 | 1907 | 0.100 |
Why?
|
Spinal Dysraphism | 1 | 2013 | 161 | 0.100 |
Why?
|
Elastomers | 1 | 2010 | 71 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1972 | 0.090 |
Why?
|
Citric Acid | 1 | 2010 | 126 | 0.090 |
Why?
|
Immunomodulation | 1 | 2013 | 541 | 0.090 |
Why?
|
Rats, Nude | 3 | 2014 | 105 | 0.080 |
Why?
|
Hospitals, Pediatric | 1 | 2017 | 1775 | 0.080 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2013 | 496 | 0.080 |
Why?
|
Bacterial Proteins | 1 | 2021 | 3848 | 0.080 |
Why?
|
Fetal Blood | 1 | 2013 | 1318 | 0.070 |
Why?
|
Polymers | 2 | 2013 | 1621 | 0.070 |
Why?
|
Muscle, Smooth | 1 | 2010 | 934 | 0.070 |
Why?
|
Animals | 8 | 2023 | 168757 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39050 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5391 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1790 | 0.060 |
Why?
|
Stem Cell Transplantation | 1 | 2013 | 1620 | 0.060 |
Why?
|
Colostomy | 1 | 2024 | 99 | 0.060 |
Why?
|
Enema | 1 | 2024 | 141 | 0.060 |
Why?
|
Protein Conformation | 2 | 2021 | 4011 | 0.060 |
Why?
|
Humans | 14 | 2024 | 744343 | 0.050 |
Why?
|
Myography | 1 | 2023 | 109 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2010 | 2513 | 0.050 |
Why?
|
Child | 5 | 2022 | 77709 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2727 | 0.050 |
Why?
|
Tissue Scaffolds | 3 | 2014 | 956 | 0.050 |
Why?
|
Male | 6 | 2023 | 350118 | 0.050 |
Why?
|
Mice | 3 | 2023 | 81183 | 0.050 |
Why?
|
Immunotoxins | 1 | 2021 | 179 | 0.050 |
Why?
|
Urodynamics | 1 | 2021 | 347 | 0.040 |
Why?
|
Electric Impedance | 1 | 2023 | 729 | 0.040 |
Why?
|
Mesenchymal Stem Cells | 1 | 2010 | 1632 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2013 | 3864 | 0.040 |
Why?
|
Infant Care | 1 | 2019 | 183 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2021 | 571 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2021 | 63114 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2021 | 3129 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2013 | 5442 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1119 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2023 | 21827 | 0.030 |
Why?
|
Body Weight | 1 | 2023 | 4669 | 0.030 |
Why?
|
Eating | 1 | 2019 | 1536 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35421 | 0.030 |
Why?
|
Binding Sites | 1 | 2021 | 6114 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.030 |
Why?
|
Rats | 3 | 2014 | 24260 | 0.030 |
Why?
|
Female | 7 | 2023 | 380194 | 0.030 |
Why?
|
Methyl Green | 1 | 2010 | 6 | 0.020 |
Why?
|
Models, Molecular | 1 | 2021 | 5456 | 0.020 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2010 | 72 | 0.020 |
Why?
|
Azo Compounds | 1 | 2010 | 113 | 0.020 |
Why?
|
Elastic Modulus | 1 | 2010 | 214 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2013 | 1341 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 11725 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9386 | 0.020 |
Why?
|
Aged | 2 | 2019 | 163280 | 0.020 |
Why?
|
Adult | 2 | 2021 | 214055 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4931 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2013 | 2124 | 0.020 |
Why?
|
Intestine, Small | 1 | 2014 | 1241 | 0.020 |
Why?
|
Nerve Regeneration | 1 | 2013 | 788 | 0.020 |
Why?
|
Middle Aged | 2 | 2019 | 213383 | 0.020 |
Why?
|
Infant | 2 | 2019 | 35136 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14557 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16365 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2010 | 1100 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2505 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1351 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9849 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7181 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2021 | 9274 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10397 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3036 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2013 | 1880 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2024 | 77449 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 7729 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 2958 | 0.010 |
Why?
|
Neutrophils | 1 | 2014 | 3719 | 0.010 |
Why?
|
Collagen | 1 | 2010 | 2689 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 2872 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18370 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5882 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5655 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 25625 | 0.010 |
Why?
|
Adolescent | 2 | 2017 | 85781 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23338 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2017 | 15295 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 41006 | 0.010 |
Why?
|
Neoplasms | 1 | 2021 | 21683 | 0.010 |
Why?
|
United States | 1 | 2017 | 69872 | 0.010 |
Why?
|
Concepts
(134)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_